Laser ruler for colon polyps could sharpen cancer risk checks

NCT ID NCT05489380

Completed Diagnosis Sponsor: Radboud University Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new laser-based device (AccuMeasure) to measure the size of colon polyps during a colonoscopy. Accurate polyp size is important because it helps doctors decide how often patients need follow-up screenings to prevent colorectal cancer. The study involved 138 adults and compared the laser measurements to standard methods like optical estimates and biopsy forceps. The goal was to see if the laser device reduces measurement differences between doctors and improves surveillance recommendations.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AccuMeasure laser-based polyp measurement device
What this could lead to: If successful, this device could help doctors more accurately measure polyps during colonoscopy, leading to better surveillance intervals and potentially reducing the risk of colorectal cancer.
What could go wrong: This is a small, completed study with 138 participants, so results may not apply to everyone. The device may not be more accurate than current methods, and there is always a risk of measurement errors or device issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL POLYP are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

polyp of large intestine

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COLORECTAL POLYP

Contacts and locations

Locations

Indiana University Hospital

Indianapolis, Indiana, 46202, United States
NYU Langone Health

New York, New York, 330306, United States
Radboud university medical center

Nijmegen, Gelderland, 6525GA, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.